Vitalibis, Inc.
VCBDQ · OTC
9/30/2020 | 6/30/2020 | 3/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.18 | 0.00 | 0.01 | -0.01 |
| FCF Yield | -2.15% | -44.77% | -10.30% | -2.78% |
| EV / EBITDA | 1.88 | 2.06 | -21.07 | -4.11 |
| Quality | ||||
| ROIC | -21.80% | -14.31% | 45.88% | 6,915.23% |
| Gross Margin | 42.43% | 47.05% | 56.90% | 60.48% |
| Cash Conversion Ratio | 1.52 | 0.07 | 0.13 | 0.09 |
| Growth | ||||
| Revenue 3-Year CAGR | 89.27% | 226.64% | 597,831.77% | 671,702.53% |
| Free Cash Flow Growth | 86.65% | 49.59% | 35.41% | 39.00% |
| Safety | ||||
| Net Debt / EBITDA | -0.02 | -0.26 | -11.32 | -0.59 |
| Interest Coverage | -0.80 | -0.14 | -0.51 | -17.25 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.08 | 0.00 | 0.10 |
| Cash Conversion Cycle | 0.00 | 1,162.94 | 0.00 | 877.74 |